Literature DB >> 19008346

Regionally specified human neural progenitor cells derived from the mesencephalon and forebrain undergo increased neurogenesis following overexpression of ASCL1.

Hyun-Jung Kim1, Erin McMillan, Fabin Han, Clive N Svendsen.   

Abstract

Human neural progenitor cells (hNPC) derived from the developing brain can be expanded in culture and subsequently differentiated into neurons and glia. They provide an interesting source of tissue for both modeling brain development and developing future cellular replacement therapies. It is becoming clear that hNPC are regionally and temporally specified depending on which brain region they were isolated from and its developmental stage. We show here that hNPC derived from the developing cortex (hNPC(CTX)) and ventral midbrain (hNPC(VM)) have similar morphological characteristics and express the progenitor cell marker nestin. However, hNPC(CTX) cultures were highly proliferative and produced large numbers of neurons, whereas hNPC(VM) divided slowly and produced fewer neurons but more astrocytes. Microarray analysis revealed a similar expression pattern for some stemness markers between the two growing cultures, overlaid with a regionally specific profile that identified some important differentially expressed neurogenic transcription factors. By overexpressing one of these, the transcription factor ASCL1, we were able to regain neurogenesis from hNPC(VM) cultures, which produced larger neurons with more neurites than hNPC(CTX) but no fully mature dopamine neurons. Thus, hNPC are regionally specified and can be induced to undergo neurogenesis following genetic manipulation. Although this restores neuronal production with a region-specific phenotype, it does not restore full neurochemical maturation, which may require additional factors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19008346     DOI: 10.1634/stemcells.2007-1047

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  28 in total

1.  Directed differentiation of functional astroglial subtypes from human pluripotent stem cells.

Authors:  Robert Krencik; Su-Chun Zhang
Journal:  Nat Protoc       Date:  2011-10-13       Impact factor: 13.491

2.  A cGMP-applicable expansion method for aggregates of human neural stem and progenitor cells derived from pluripotent stem cells or fetal brain tissue.

Authors:  Brandon C Shelley; Geneviève Gowing; Clive N Svendsen
Journal:  J Vis Exp       Date:  2014-06-15       Impact factor: 1.355

Review 3.  Transcriptional deregulation underlying the pathogenesis of small cell lung cancer.

Authors:  Dong-Wook Kim; Keun-Cheol Kim; Kee-Beom Kim; Colin T Dunn; Kwon-Sik Park
Journal:  Transl Lung Cancer Res       Date:  2018-02

Review 4.  Mesenchymal stem cells for the treatment of neurodegenerative disease.

Authors:  Nanette Joyce; Geralyn Annett; Louisa Wirthlin; Scott Olson; Gerhard Bauer; Jan A Nolta
Journal:  Regen Med       Date:  2010-11       Impact factor: 3.806

5.  Innate neural stem cell heterogeneity determines the patterning of glioma formation in children.

Authors:  Da Yong Lee; Scott M Gianino; David H Gutmann
Journal:  Cancer Cell       Date:  2012-07-10       Impact factor: 31.743

Review 6.  Progress in stem cell therapy for major human neurological disorders.

Authors:  P L Martínez-Morales; A Revilla; I Ocaña; C González; P Sainz; D McGuire; I Liste
Journal:  Stem Cell Rev Rep       Date:  2013-10       Impact factor: 5.739

7.  Direct reprogramming of human astrocytes into neural stem cells and neurons.

Authors:  Stefania Corti; Monica Nizzardo; Chiara Simone; Marianna Falcone; Chiara Donadoni; Sabrina Salani; Federica Rizzo; Martina Nardini; Giulietta Riboldi; Francesca Magri; Chiara Zanetta; Irene Faravelli; Nereo Bresolin; Giacomo P Comi
Journal:  Exp Cell Res       Date:  2012-03-08       Impact factor: 3.905

8.  Treatment of adult MPSI mouse brains with IDUA-expressing mesenchymal stem cells decreases GAG deposition and improves exploratory behavior.

Authors:  Flávia Helena da Silva; Vanessa Gonçalves Pereira; Eduardo G Yasumura; Lígia Zacchi Tenório; Leonardo Pinto de Carvalho; Bianca Cristina Garcia Lisboa; Priscila Keiko Matsumoto; Roberta Sessa Stilhano; Vivian Y Samoto; Bruno Frederico Aguilar Calegare; Letícia de Campos Brandão; Vânia D'Almeida; Thaís Rm Filippo; Marimélia Porcionatto; Leny Toma; Helena Bonciani Nader; Valderez Bastos Valero; Melissa Camassola; Nance Beyer Nardi; Sang Won Han
Journal:  Genet Vaccines Ther       Date:  2012-04-20

9.  Comparison of ectopic gene expression methods in rat neural stem cells.

Authors:  Woosuk Kim; Ji Hyeon Kim; Sun-Young Kong; Min-Hye Park; Uy Dong Sohn; Hyun-Jung Kim
Journal:  Korean J Physiol Pharmacol       Date:  2013-02-14       Impact factor: 2.016

10.  Clonal human fetal ventral mesencephalic dopaminergic neuron precursors for cell therapy research.

Authors:  Tania Ramos-Moreno; Javier G Lendínez; María José Pino-Barrio; Araceli Del Arco; Alberto Martínez-Serrano
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.